SCHEMBL5210554

SCHEMBL5210554

CCCN1CCC(OC2CCN(c3ccc(C(C)=O)cc3)CC2)CC1

nearest known ligand 0.50

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 1/20 0.47
KMT2A Q03164 4/20 0.46
MAPT P10636 3/20 0.46
ALDH1A1 P00352 2/20 0.46
MEN1 O00255 2/20 0.46
DRD2 P14416 2/20 0.45
HRH3 Q9Y5N1 2/20 0.45
MAPK1 P28482 1/20 0.44
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
KDM4E B2RXH2 1/20 0.43
LMNA P02545 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
USP2 O75604 1/20 0.43
HTR7 P34969 1/20 0.42
SIGMAR1 Q99720 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4032439 0.86 KMT2A (0.47) GPR119KMT2AMAPTALDH1A1MEN1
SCHEMBL5213714 0.85 HRH1 (0.52) GPR119KMT2AMAPTALDH1A1MEN1
SCHEMBL11736036 0.83 DRD2 (0.60) KMT2AMAPTALDH1A1MEN1DRD2
SCHEMBL14431627 0.83 KMT2A (0.47) GPR119KMT2AMAPTALDH1A1MEN1
SCHEMBL5209078 0.80 GPR119 (0.46) GPR119KMT2AMAPTALDH1A1MEN1
SCHEMBL5212473 0.80 GPR119 (0.46) GPR119KMT2AMAPTALDH1A1MEN1
SCHEMBL5210189 0.79 HRH3 (0.50) GPR119KMT2AMAPTALDH1A1MEN1
SCHEMBL5209386 0.78 KMT2A (0.57) GPR119KMT2AMAPTALDH1A1MEN1
Hydrochloric Acid SCHEMBL5213050 0.77 KMT2A (0.56) GPR119KMT2AMAPTALDH1A1MEN1
SCHEMBL24725739 0.75 KMT2A (0.53) GPR119KMT2AMAPTALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1646620-B1 SUBSTITUTED PIPERIDINES AS HISTAMINE H3 RECEPTOR LIGANDS GLAXO GROUP LTD (GB) 2007-08-15 EP disclosed
US-20060247227-A1 Substituted piperidines as histamine h3 receptor ligands BAILEY JAMES M 2006-11-02 US disclosed
EP-1646620-A1 SUBSTITUTED PIPERIDINES AS HISTAMINE H3 RECEPTOR LIGANDS GLAXO GROUP LIMITED (GB) 2006-04-19 EP disclosed
WO-2005014571-A1 SUBSTITUTED PIPERIDINES AS HISTAMINE H3 RECEPTOR LIGANDS GLAXO GROUP LIMITED (GB) 2005-02-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060247227-A1 Substituted piperidines as histamine h3 receptor ligands HRH3, HRH4, HRH1 GPR119 216/4885KMT2A 281/4885MAPT 575/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.